Luigi Naldini: Gene therapy no longer a ‘dream’ but big pharma must step up
In the realm of modern medicine, few advancements have inspired and challenged the industry quite like gene therapy.
Archives for March 7, 2024
AstraZeneca to invest £650m in UK, boosting ‘pandemic preparedness’
Despite previously calling the UK a ‘very unattractive’ place to do business, AstraZeneca CEO Pascal Soriot is injecting £650 million into the UK life sciences industry.
Empros Pharma could join lucrative obesity drug market with oral alternative
Swedish-based company Empros Pharma has announced positive topline data from its phase 2b trial investigating EMP16, an oral therapy for the treatment of obesity.